Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvox's Patient Share in the Treatment of Nosocomial... ( Most Important Factors Driving N...)

HOME >> MEDICINE >> TECHNOLOGY

Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvox's Patient Share in the Treatment of Nosocomial Pneumonia

Date:9/22/2008

Most Important Factors Driving Nosocomial Pneumonia Prescribing in

Hospitals Are Infectious Disease Consults and ATS/IDSA Guidelines

Arlington Medical Resources and Decision Resources Introduce the New

Hospital Anti-Infectives Insight Series

MALVERN, Penn. and WALTHAM, Mass., Sept. 22 /PRNewswire/ -- Arlington Medical Resources (AMR) and Decision Resources find that over 80 percent of surveyed hospital physicians estimate that if approved, Basilea/Johnson & Johnson's ceftobiprole will steal, on average, nearly a third of Pfizer's Zyvox patient share in the treatment of nosocomial pneumonia. In addition, several product profiles that are analogous to ceftobiprole and other antibiotics were presented to physicians to see how they would compete within the nosocomial pneumonia drug market. The new report entitled Hospital Anti-Infectives Insight Series: Nosocomial Pneumonia found that the ceftobiprole analogue profile is well positioned to compete in this drug market.

"We presented several antibiotic product profiles to physicians we surveyed that are analogous to ceftobiprole, Forest's ceftaroline in combination with a beta-lactamase inhibitor and Theravance/Astellas's telavancin to assess the potential positioning of these agents in the future nosocomial pneumonia market," states John Lebbos, M.D., Vice President of Infectious Diseases at Decision Resources. "Physicians were highly receptive to these profiles -- in fact, 67 percent of physicians indicated that the ceftobiprole analogue profile is well positioned to compete in the large empiric, first-line therapy market for nosocomial pneumonia."

The report also finds that hospital prescribing patterns are mainly driven by an institution's infectious disease consults and by guidelines presented by the American Thoracic Society (ATS) and the Infectious Disease Society of America (IDSA). A hospital's protocol and local guidelines play the next important role.
'/>"/>

SOURCE Arlington Medical Resources; Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Mayo Clinic Physicians Report Findings from Research on Sleep Disorders
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
4. Physicians Will Benefit from Medical Software Advice Website
5. Physicians Reconsider Implications of Enhance Trial
6. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
7. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
8. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
9. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
10. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections
11. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline

Post Your Comments:

(Date:6/19/2013)... 19, 2013 Voices Against Brain Cancer ... for brain cancer, today announced that it has awarded ... the clinical investigation of Toca 511 & Toca FC ... brain cancer (Grade 3 or Grade 4). Tocagen is ... advanced cancer, with an initial focus on brain cancer. ...

(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ -- Chindex International, ... American healthcare company providing services in ... Family Healthcare, a network of private hospitals and ... of its Beijing United Family Rehabilitation Hospital ("BJU ... of the United Family Healthcare ("UFH") network. On ...

(Date:6/19/2013)... June 19, 2013 BD Biosciences, a segment of ... a leading global medical technology company, today announced the launch ... latest in its line of high-performance research flow cytometers. ... multicolor analysis with the most compact footprint in its class ... a height of 30" (76.2 cm). Recognizing that space is ...

Breaking Medicine Technology:Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2 Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5 New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2

[0] Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer [0] Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital [0] New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research

... Gene Expression in Female and Male Patients Presented at ASCO ... (Nasdaq: GHDX ) today announced results from a ... type DX(R) breast cancer test in a large number ... guide treatment with chemotherapy. The results, which will be presented ...

... ET Today CORAL GABLES, Fla., May 29 ... today announced top-line results from its U.S. Phase II ... from the trial showed that CPP-109 did not demonstrate ... significantly larger proportion of CPP-109-treated subjects than placebo-treated subjects ...

Cached Medicine Technology:Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 2 Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 3 Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 4 Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 5 Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 2 Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 3 Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction 4

Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction

(Date:6/19/2013)... CA (PRWEB) June 19, 2013 Alternatives, ... permits some patients to quit using drugs while allowing ... Adi Jaffe, the founders of Alternatives, believe that abstinence-only ... before they enter treatment and that this approach hurts ... million people in the United States need treatment for ...

(Date:6/19/2013)... St. Louis, MO (PRWEB) June 19, 2013 ... solutions organization, partnered with ARAMARK Healthcare Technologies to ... equipment management plan with savings of more than ... repair and maintenance service expenditures. , “Driving economies ... the top medical equipment management challenges facing multi-site ...

(Date:6/19/2013)... a world-leading provider of scientific, technical and medical ... of the National Osteoporosis Guideline Group (NOGG) Update ... postmenopausal women and older men in the journal ... Maturitas , the original guidelines have been ... an additional focus on the management of glucocorticoid-induced ...

(Date:6/19/2013)... Mass. (PRWEB) June 19, 2013 ... security solutions, today announced that Imprivata OneSign ® ... KLAS® 2013 Mid-Term Performance Review: Software & Services report ... KLAS laud Imprivata on the superior performance of its ... support, and they indicate that Imprivata is integral to ...

(Date:6/19/2013)... According to Transparency Market Research “Endoscopy devices Market ... Forecast, 2011 – 2017,” the global endoscopy devices market ... and is expected to reach USD 10.8 billion by ... to 2017. Flexible endoscopes formed the largest category in ... for the year 2011. , Related Report : Medical ...

Breaking Medicine News(10 mins):Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2 Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3 Health News:Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program 2 Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2 Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3 Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 2 Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 3

[0] Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment [0] Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program [0] Maturitas publishes 2013 update on diagnosis and management of osteoporosis [0] Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review [0] Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research

... NEW YORK, Aug. 7 Duane Reade Holdings, Inc. ... previously announced offers by its wholly-owned subsidiaries, Duane Reade Inc. ... (i) any and all of the Issuers, $210,000,000 outstanding aggregate ... 2010 (the "Floating Rate Notes") (the "FRN Offer") and (ii) ...

... , NEW YORK, Aug. 7 WebMD ... HLTH ) today announced that executives of WebMD are scheduled to ... August 12, 2009 at 1:00 p.m. ET. , , ... to a live audio broadcast of the presentation over the Internet. ...

... The poll results come on the heels of the federal government,s new H1N1 ... A poll conducted by the American Red Cross shows that while a majority ... a third of parents (39%) have received no flu information from their children,s ... http://www.newscom.c o m/cgi-bin/prnh/20090108/RedCrossLOGO ) , , ...

... government to preserve study options , FRIDAY, Aug. 7 (HealthDay ... lines are routinely used by researchers in the United States, says ... known as H1 and H9, accounted for 941 of 1,217 requests, ... stem cell lines housed at the two largest stem cell banks ...

... INDIANAPOLIS Poor communication of the outcomes of medical ... a patient,s hospital discharge is common and can lead ... A new study by researchers from the Regenstrief ... found that hospital discharge summaries are grossly inadequate at ...

... , , WASHINGTON, Aug. 7 "The differences between ... policy experts," say former Chief of Staff to the House Aging Committee ... Americans, lives." , , In an op-ed column in ... Osserman contend, "With no public option, the Senate Finance bill, developed by ...

Cached Medicine News:Health News:Duane Reade Holdings, Inc. Announces Expiration and Results of Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes and Solicitation of Consents to Related Indentures 2 Health News:Duane Reade Holdings, Inc. Announces Expiration and Results of Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes and Solicitation of Consents to Related Indentures 3 Health News:Red Cross Poll Shows Parents Still Lack H1N1 Information From Schools 2 Health News:U.S. Stem Cell Research Seems to Focus on Two Lines 2 Health News:Fumbled handoffs can lead to medical errors 2 Health News:Ex-House Aging Committee Chief of Staff Bob Weiner Warns of Insurance Control Over Health Bill Outcome, Praises House Version, 'Disappointed' by Senate; Weiner and Policy Analyst Jordan Osserman Offer Bill's 'Prognosis' 2

Duane Reade Holdings, Inc. Announces Expiration and Results of Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes and Solicitation of Consents to Related Indentures WebMD to Present at the Canaccord Adams 29th Annual Global Growth Conference Red Cross Poll Shows Parents Still Lack H1N1 Information From Schools U.S. Stem Cell Research Seems to Focus on Two Lines Fumbled handoffs can lead to medical errors Ex-House Aging Committee Chief of Staff Bob Weiner Warns of Insurance Control Over Health Bill Outcome, Praises House Version, 'Disappointed' by Senate; Weiner and Policy Analyst Jordan Osserman Offer Bill's 'Prognosis'

Malaria Pf. Assay Range...

An immunochromatographic test for detection of 4 species of Plasmodium antigen ( P. falciparum , P. vivax , P. malariae , P. ovale ) in whole blood....

192 Test HRP-II Enzyme Immunoassay for the presence of Plasmodium falciparum infection....

Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)...

Medicine Products:

Malaria Pf. Assay Range PALUTOP+4 Malaria Antigen CELISA Malaria Device / Strip (3 line, PAN-pLDH, P.f.-HRP2)